Therapeutic Product Immunogenicity Community

 View Only
  • 1.  Immunogenicity Discussion Group - Nov 5th | 12PM EST

    Community Leadership
    Posted 11-03-2025 16:38
      |   view attached

    Join us this Wednesday | Nov 5th | 12pm EST for the next Immunogenicity Discussion Group.

    We will host @Michael Partridge, @Joleen White, et al. to present and discuss the recent publication, Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays.

    https://link.springer.com/article/10.1208/s12248-025-01118-6

    Link to Teams meeting below.

    Todd & Rob

    Microsoft Teams 

    Join the meeting now

    Meeting ID: 230 923 966 577

    Passcode: ZyRwNR


    Dial-in by phone

    +1 910-745-0533,,871809719# United States, Fayetteville

    Find a local number

    Phone conference ID: 871 809 719#



    ------------------------------
    Todd Lester
    BioAgilytix | Senior Director
    Durham, NC | [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Attachment(s)

    pdf
    s12248-025-01118-6.pdf   874 KB 1 version


  • 2.  RE: Immunogenicity Discussion Group - Nov 5th | 12PM EST

    Community Leadership
    Posted 12-09-2025 06:30

    For those unable to join the discussion on the recent AAPS Journal white paper 'Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays', it is available on demnad: here



    ------------------------------
    Robert Nelson
    Scientific Officer, Executive Director
    BioAgilytix Laboratories
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------